171 related articles for article (PubMed ID: 18195213)
1. Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans.
Vemulakonda GA; Hariprasad SM; Mieler WF; Prince RA; Shah GK; Van Gelder RN
Arch Ophthalmol; 2008 Jan; 126(1):18-22. PubMed ID: 18195213
[TBL] [Abstract][Full Text] [Related]
2. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans.
Hariprasad SM; Mieler WF; Holz ER; Gao H; Kim JE; Chi J; Prince RA
Arch Ophthalmol; 2004 Jan; 122(1):42-7. PubMed ID: 14718293
[TBL] [Abstract][Full Text] [Related]
3. Comparison of voriconazole concentration in the aqueous humor and vitreous between non-scraped and scraped corneal epithelium groups after topical 1% voriconazole application.
Wei LC; Tsai TC; Tsai HY; Wang CY; Shen YC
Curr Eye Res; 2010 Jul; 35(7):573-9. PubMed ID: 20597643
[TBL] [Abstract][Full Text] [Related]
4. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous.
Hariprasad SM; Blinder KJ; Shah GK; Apte RS; Rosenblatt B; Holekamp NM; Thomas MA; Mieler WF; Chi J; Prince RA
Arch Ophthalmol; 2005 Jan; 123(1):39-44. PubMed ID: 15642810
[TBL] [Abstract][Full Text] [Related]
5. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
Thiel MA; Zinkernagel AS; Burhenne J; Kaufmann C; Haefeli WE
Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
[TBL] [Abstract][Full Text] [Related]
6. Clearance of intravitreal voriconazole.
Shen YC; Wang MY; Wang CY; Tsai TC; Tsai HY; Lee YF; Wei LC
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2238-41. PubMed ID: 17460285
[TBL] [Abstract][Full Text] [Related]
7. Penetration of voriconazole, 1%, eyedrops into human aqueous humor: a prospective open-label study.
Lau D; Fedinands M; Leung L; Fullinfaw R; Kong D; Davies G; Daniell M
Arch Ophthalmol; 2008 Mar; 126(3):343-6. PubMed ID: 18332313
[TBL] [Abstract][Full Text] [Related]
8. Aqueous humor concentration of voriconazole after topical administration in rabbits.
Vorwerk CK; Streit F; Binder L; Tuchen S; Knop C; Behrens-Baumann W
Graefes Arch Clin Exp Ophthalmol; 2008 Aug; 246(8):1179-83. PubMed ID: 18491124
[TBL] [Abstract][Full Text] [Related]
9. Penetration of 1% voriconazole eye drops into human vitreous humour: a prospective, open-label study.
Lau D; Leung L; Ferdinands M; Allen PJ; Fullinfaw RO; Davies GE; Kong DC
Clin Exp Ophthalmol; 2009 Mar; 37(2):197-200. PubMed ID: 19723128
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses.
Clode AB; Davis JL; Salmon J; Michau TM; Gilger BC
Am J Vet Res; 2006 Feb; 67(2):296-301. PubMed ID: 16454636
[TBL] [Abstract][Full Text] [Related]
11. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
[TBL] [Abstract][Full Text] [Related]
12. Human intraocular penetration pharmacokinetics of moxifloxacin 0.5% via topical and collagen shield routes of administration.
Hariprasad SM; Mieler WE; Shah GK; Blinder KJ; Apte RS; Holekamp NM; Thomas MA; Chi J; Prince RA
Trans Am Ophthalmol Soc; 2004; 102():149-55; discussion 155-7. PubMed ID: 15747753
[TBL] [Abstract][Full Text] [Related]
13. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
Hariprasad SM; Shah GK; Mieler WF; Feiner L; Blinder KJ; Holekamp NM; Gao H; Prince RA
Arch Ophthalmol; 2006 Feb; 124(2):178-82. PubMed ID: 16476886
[TBL] [Abstract][Full Text] [Related]
14. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
15. Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration.
Fiscella RG; Lai WW; Buerk B; Khan M; Rodvold KA; Pulido JS; Labib S; Shapiro MJ; Blair NP
Ophthalmology; 2004 Jun; 111(6):1191-5. PubMed ID: 15177970
[TBL] [Abstract][Full Text] [Related]
16. Vitreous penetration of orally administered gatifloxacin in humans.
Hariprasad SM; Mieler WF; Holz ER
Trans Am Ophthalmol Soc; 2002; 100():153-9. PubMed ID: 12545689
[TBL] [Abstract][Full Text] [Related]
17. Vitreous and aqueous penetration of orally administered moxifloxacin in humans.
Vedantham V; Lalitha P; Velpandian T; Ghose S; Mahalakshmi R; Ramasamy K
Eye (Lond); 2006 Nov; 20(11):1273-8. PubMed ID: 16200061
[TBL] [Abstract][Full Text] [Related]
18. Vitreous and aqueous penetration of orally administered gatifloxacin in humans.
Hariprasad SM; Mieler WF; Holz ER
Arch Ophthalmol; 2003 Mar; 121(3):345-50. PubMed ID: 12617704
[TBL] [Abstract][Full Text] [Related]
19. Penetration of ofloxacin in human aqueous and vitreous humors following oral and topical administration.
Cekic O; Batman C; Yasar U; Basci NE; Bozkurt A; Kayaalp SO
Retina; 1998; 18(6):521-5. PubMed ID: 9869460
[TBL] [Abstract][Full Text] [Related]
20. Penetration of topically applied ciprofloxacin and ofloxacin into the aqueous humor and vitreous.
Yalvac IS; Basci NE; Bozkurt A; Duman S
J Cataract Refract Surg; 2003 Mar; 29(3):487-91. PubMed ID: 12663011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
